ETR:AFX Carl Zeiss Meditec (AFX) Stock Price, News & Analysis €64.80 +3.00 (+4.85%) (As of 10/18/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlines About Carl Zeiss Meditec Stock (ETR:AFX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Carl Zeiss Meditec alerts:Sign Up Key Stats Today's Range€62.30▼€65.1050-Day Range€55.75▼€71.1552-Week Range€54.60▼€123.75Volume249,826 shsAverage Volume94,405 shsMarket Capitalization$5.80 billionP/E Ratio28.42Dividend Yield1.70%Price TargetN/AConsensus RatingN/A Company OverviewCarl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.Read More… New gold frenzy underway (Ad)Gold: Now legal tender Most Americans missed this big story, but 1 in 5 states have now made gold and silver coins legal tender. It's just one reason why so many predict gold will soon hit $5,000. And why you need to check out this $6 strategy for gold immediately.Click here for full details. Receive AFX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter. Email Address AFX Stock News HeadlinesIs Carl Zeiss Meditec AG's (ETR:AFX) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?October 14, 2024 | finance.yahoo.comChesterfield-based tech and optics business makes $24M expansion, adds 40 jobsSeptember 30, 2024 | bizjournals.comNew gold frenzy underwayGold: Now legal tender Most Americans missed this big story, but 1 in 5 states have now made gold and silver coins legal tender. It's just one reason why so many predict gold will soon hit $5,000. And why you need to check out this $6 strategy for gold immediately.October 21, 2024 | Stansberry Research (Ad)ZEISS introduces its latest Robotic Visualisation System for neuro surgerySeptember 30, 2024 | tmcnet.comWhat Is Carl Zeiss Meditec AG's (ETR:AFX) Share Price Doing?September 30, 2024 | finance.yahoo.comJ.P. Morgan Remains a Sell on Carl Zeiss Meditec (0DHC)September 13, 2024 | markets.businessinsider.comKepler Capital Reaffirms Their Hold Rating on Carl Zeiss Meditec (0DHC)September 12, 2024 | markets.businessinsider.comThe three-year loss for Carl Zeiss Meditec (ETR:AFX) shareholders likely driven by its shrinking earningsSeptember 2, 2024 | finance.yahoo.comSee More Headlines AFX Stock Analysis - Frequently Asked Questions How have AFX shares performed this year? Carl Zeiss Meditec's stock was trading at €98.84 on January 1st, 2024. Since then, AFX stock has decreased by 34.4% and is now trading at €64.80. View the best growth stocks for 2024 here. What other stocks do shareholders of Carl Zeiss Meditec own? Based on aggregate information from My MarketBeat watchlists, some other companies that Carl Zeiss Meditec investors own include Intel (INTC), Meta Platforms (META), NVIDIA (NVDA), Volkswagen (VOW3), AbbVie (ABBV), Chevron (CVX) and Siemens Aktiengesellschaft (SIE). Industry, Sector and Symbol Stock ExchangeETR SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolETR:AFX CUSIPN/A CIKN/A Webwww.zeiss.com Phone+49-3641-2200FaxN/AEmployees4,950Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)€2.28 Trailing P/E Ratio28.42 Forward P/E Ratio22.18 P/E Growth2.83Net Income$203.20 million Net Margins9.83% Pretax MarginN/A Return on Equity12.83% Return on Assets7.03% Debt Debt-to-Equity Ratio6.74 Current Ratio3.51 Quick Ratio2.47 Sales & Book Value Annual Sales$2.07 billion Price / Sales2.80 Cash Flow€0.05 per share Price / Cash Flow1,398.28 Book Value€23.42 per share Price / Book2.77Miscellaneous Outstanding Shares89,440,000Free FloatN/AMarket Cap$5.80 billion OptionableNot Optionable Beta0.98 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report This page (ETR:AFX) was last updated on 10/21/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredAfter calling a 2,269% gain, here’s his NEXT tradeReady for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredCostco gold maniaIs Gold Headed Above $3,000 per Ounce? Here's How to Play It… With so many strange events happening across ...Stansberry Research | SponsoredNotice: Major payout due November 19th - are you on the list?On Tuesday, November 19, 2024 smart investors will collect their share of a $1.2 billion windfall... It's p...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored[SHOCKING] Crypto Document Leak…The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carl Zeiss Meditec AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Carl Zeiss Meditec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.